A Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety, Tolerability and Efficacy of TRC101 in Subjects With Chronic Kidney Disease and Low Serum Bicarbonate Levels
Phase of Trial: Phase I/II
Latest Information Update: 08 Nov 2017
At a glance
- Drugs TRC 101 (Primary)
- Indications Acidosis; Kidney disorders; Renal failure
- Focus Adverse reactions; First in man
- Sponsors Tricida
- 08 Nov 2017 According to a Tricida media release, the results of this trial have been published in the Clinical Journal of the American Society of Nephrology (CJASN).
- 01 Nov 2017 According to Tricida media release, data from this trial will be presented at ASN Kidney Week 2017 .
- 09 Jan 2017 Topline results published in a Tricida media release.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History